Sharps Technology, Inc. (STSS)
Automate Your Wheel Strategy on STSS
With Tiblio's Option Bot, you can configure your own wheel strategy including STSS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol STSS
- Rev/Share 0.0
- Book/Share 202.9582
- PB 0.027
- Debt/Equity 0.0
- CurrentRatio 1.6132
- ROIC -0.8167
- MktCap 5594733.0
- FreeCF/Share -141.5425
- PFCF -0.7915
- PE -0.0429
- Debt/Assets 0.0
- DivYield 0
- ROE -0.9878
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 3
- P/B Score 5
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Sharps Technology Shares Climb on Latest SoloGard Shipments
Published: June 18, 2025 by: Market Watch
Sentiment: Positive
Shares of Sharps Technology jumped after the company said it has initiated a second shipment from its first commercial order of SoloGard syringes.
Read More
Sharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025
Published: June 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, will present at the Virtual Investor Summit on June 10, 2025, at 10:00 AM ET. Investors are invited to listen to the presentation and can register here.
Read More
Sharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing Rule
Published: May 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, announces that it has received a notice from Nasdaq confirming that the Company has regained compliance with The Nasdaq's Capital Market's minimum bid price requirement of $1.00 per share and the minimum stockholders' equity requirement of $2.5 million.
Read More
Sharps Technology to Present at the Aegis Capital Corp. 2025 Virtual Conference on May 22nd
Published: May 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, is scheduled to present at the Aegis Capital Corp. 2025 Virtual Conference on May 22, 2025 at 1:00 p.m. ET. Presentation Details: Presenter: Robert Hayes, CEO Date: May 22, 2025 Time: 1:00 p.m.
Read More
Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on March 28, 2025
Published: March 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: STSS) (the “Company” or “Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is reminding shareholders to vote their proxy in favor of the Company's proposal before the shareholder meeting, which is scheduled to be held on March 28, 2025, at 10:00 a.m. Eastern Time.
Read More
About Sharps Technology, Inc. (STSS)
- IPO Date 2022-04-14
- Website https://sharpstechnology.com
- Industry Medical - Instruments & Supplies
- CEO Robert M. Hayes
- Employees 55